Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan

• Conditions: Urothelial Carcinoma

• Registration Number: NCT00867633
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

To study the association between aristolochic acid and urothelial carcinoma in Taiwan

Detailed Description

Not available

Study Timeline

• Study Start: 2009-03
• Study First Submitted: 2009-03-22
• Study First Submitted QC: 2009-03-22
• Study First Posted: 2009-03-24
• Status Verified: 2012-02
• Last Update Submitted: 2012-02-20
• Last Update Posted: 2012-02-22
• Study Completion: 2012-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• the resected kidney tissue in the tissue bank

Read More

Exclusion Criteria

• the patients who had been ever exposed to arsenics, rubber, chemicals, irradiation for pelvis, or received chemotherapy.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the incidence of aristolochic-acid DNA adduct in the samples	one week

Trial Locations

Locations (1)

National Taiwan University Hospital; 🇨🇳 Taipei, Taiwan